Klein, CH
Bernhard Klein, Zurich CH
Patent application number | Description | Published |
---|---|---|
20150241281 | BOLOMETER DEVICE FOR SENSING ELECTROMAGNETIC RADIATION - A bolometer device for use in a bolometer array. The bolometer device of the present invention measures radiation-induced temperature and includes a bolometer sensor and at least one holding element. The bolometer sensor includes at least two antenna elements. The antenna elements are coupled together with one of their ends at a center position. The bolometer sensor also includes a temperature sensing element attached at the center position of the at least two antenna elements, and detects a temperature at the center position. The temperature sensing element also provides an electrical measure in response to the temperature it detects. The holding elements provide support for the bolometer sensor at an end portion of one of the antenna elements. At least one of the holding elements is made of electrically conductive material so an electrical measure can be read out through the holding element. | 08-27-2015 |
Cedric Klein, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20090000658 | 2,2-Bipyridine Ligand, Sensitizing Dye and Dye Sensitized Solar Cell - A dye sensitized solar cell, comprising a-heteroleptic polypyridil complex of Ru, Os or Fe. The donating ligand has an extended conjugated n-system increasing the light absorbance and keeing the LUMO energy level higher than that of the anchoring ligand. A compacting compound whose molecular structure comprises a terminal group, a hydrophobic part and an anchoring′ group may be co-adsorbed together with the dye on the semi-conductive metal oxide layer of the photoanode, forming a dense mixed self-assembled monolayer. | 01-01-2009 |
Cêdric Klein, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20110190501 | 2, 2-Bipyridine ligand, sensitizing dye and dye sensitized solar cell - A dye sensitized solar cell, comprising a heteroleptic polypyridil complex of Ru, Os or Fe. The donating ligand has an extended conjugated n-system increasing the light absorbance and keeing the LUMO energy level higher than that of the anchoring ligand. A compacting compound whose molecular structure comprises a terminal group, a hydrophobic part and an anchoring group may be co-adsorbed together with the dye on the semi-conductive metal oxide layer of the photoanode, forming a dense mixed self-assembled monolayer. | 08-04-2011 |
Cedric Nicolas Klein, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20100044637 | ELECTRO LUMINESCENT METAL COMPLEXES - Electro luminescent metal, e.g. Ir, complexes are disclosed. The metal complexes comprise at least one ligand L1 and at least one ligand L2, wherein ligand L1 is a 2-phenylpyridine ligand (I), comprising a phenyl ring (A) and a pyridine ring (B). The integers 2 to 9 denote positions in which substitutions can be made, and by the use of different substituents, e.g. 2,4-difluoro and 7-N(CH3)2, the emission wavelength of the complex may be tuned. The ligand L2 may e.g. be a compound of the following formula (II). | 02-25-2010 |
Frieder Klein, Tagerwilen CH
Patent application number | Description | Published |
---|---|---|
20120200000 | Device and Method for Treating a Bulk Material - The invention relates to a device comprising a substantially cylindrical housing ( | 08-09-2012 |
Gabriel Klein, Montpreveyres CH
Patent application number | Description | Published |
---|---|---|
20150374249 | PERSONAL HEALTH DATA COLLECTION - This disclosure provides a personal hand-held monitor (PHHM) which comprises a signal acquisition device for acquiring signals which can be used to derive a measurement of a subject's blood pressure (BP), the signal acquisition device being integrated with a personal hand-held computing device (PHHCD). The signal acquisition device comprises a blood flow occlusion means adapted to be pressed against one side only of a body part or to have one side only of a body part pressed against it, a means for measuring the pressure applied by or to the body part, and a means for detecting the flow of blood through the body part in contact with the blood flow occlusion means. The blood flow occlusion means comprises at least part of an external surface of the PHHM and wherein the pressure is sensed by means of a flexible and essentially incompressible gel in which is immersed a pressure sensor. The pressure sensor is adapted to provide electrical signals to the processor of the PHHCD. | 12-31-2015 |
Gerard Klein, Neuchatel CH
Patent application number | Description | Published |
---|---|---|
20100303876 | METHOD FOR PREPARING SILVER NANOPARTICLES - The invention relates to a method for preparing silver nanoparticles having a diameter lower than 80 nm, and dispersed in a polymer matrix in a concentration higher than 1 M, that comprises the following steps: i) mixing an organic silver salt and a polymer having an alcohol terminal function in a solvent containing at least one alcohol fraction; ii) agitating and heating the mixture obtained during the previous step; and iii) separating the polymer phase charged with silver nanoparticles. | 12-02-2010 |
Joachim Klein, Munchen CH
Patent application number | Description | Published |
---|---|---|
20080206817 | Rhamnose Promoter Expression System - Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: | 08-28-2008 |
Joachim Klein, Visp CH
Patent application number | Description | Published |
---|---|---|
20080305526 | Melibiose Operon Expression System - New vectors expressible in a host comprising the promoter region of the melibiose operon operably linked to a transcriptional unit that includes nucleic acid sequence which is heterologous to the host. The expression of the nucleic acid sequence is controlled by the promoter region of the melibiose operon. The new vector can be used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. There is an isolated and purified nucleic acid sequence expressible in a host comprising the promoter region of the melibiose operon operably linked to a transcriptional unit that includes a nucleic acid sequence which is heterologous to the host. The expression of the nucleic acid sequence is controlled by the promoter region of the melibiose operon. A prokaryotic host is transformed with the vector or the isolated and purified nucleic acid sequence. There is a method for producing a polypeptide in a host using the vector. | 12-11-2008 |
20120077225 | Melibiose operon expression system - New vectors expressible in a host comprising the promoter region of the melibiose operon operably linked to a transcriptional unit that includes nucleic acid sequence which is heterologous to the host. The expression of the nucleic acid sequence is controlled by the promoter region of the melibiose operon. The new vector can be used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. There is an isolated and purified nucleic acid sequence expressible in a host comprising the promoter region of the melibiose operon operably linked to a transcriptional unit that includes a nucleic acid sequence which is heterologous to the host. The expression of the nucleic acid sequence is controlled by the promoter region of the melibiose operon. A prokaryotic host is transformed with the vector or the isolated and purified nucleic acid sequence. There is a method for producing a polypeptide in a host using the vector. | 03-29-2012 |
20120135463 | Rhamnose promoter expression system - Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: | 05-31-2012 |
20140242636 | REGULATABLE PROMOTER - A method of producing a protein of interest (POI) by culturing a recombinant eukaryotic cell line comprising an expression construct comprising a regulatable promoter and a nucleic acid molecule encoding a POI under the transcriptional control of said promoter, comprising the steps a) cultivating the cell line with a basal carbon source repressing the promoter, b) cultivating the cell line with a limited amount of a supplemental carbon source de-repressing the promoter to induce production of the POI at a transcription rate of at least 15% as compared to the native pGAP promoter, and c) producing and recovering the POI; and further an isolated regulatable promoter and a respective expression system. | 08-28-2014 |